Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Douglas L. Riegert‐Johnson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6007-4162; OpenAlex author ID A5062999902. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Pancreatic cancer surveillance not recommended for familial adenomatous polyposis: a fine and gray risk analysis. Co-author DOI 10.1007/s10689-025-00512-5↗
  2. Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/op.23.00447↗
  3. Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake. Last author DOI 10.1177/17588359231189127↗
  4. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations Co-author DOI 10.1016/j.gie.2021.12.001↗
  5. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review… Co-author DOI 10.1016/j.gie.2021.12.002↗
  6. Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study. Co-author DOI 10.14309/ctg.0000000000000414↗
  7. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Co-author DOI 10.1016/j.cgh.2018.04.065↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael B. Wallace · 3 shared papers, 2019–2025 · strength 0.52
  2. Talia Golan · 3 shared papers, 2022–2023 · strength 0.44
  3. Jeanin Elise van Hooft · 2 shared papers, 2024–2025 · strength 0.40
  4. Monique Esther van Leerdam · 2 shared papers, 2024–2025 · strength 0.40
  5. Derk C.F. Klatte · 2 shared papers, 2024–2025 · strength 0.40
  6. Lisa A. Boardman · 2 shared papers, 2021–2025 · strength 0.30
  7. Charles M. Vollmer · 2 shared papers, 2022 · strength 0.24
  8. Audrey H. Calderwood · 2 shared papers, 2022 · strength 0.24
  9. Marcia Irene Canto · 2 shared papers, 2022 · strength 0.24
  10. Manuel M. Hidalgo · 2 shared papers, 2022 · strength 0.24
  11. Bashar J. Qumseya · 2 shared papers, 2022 · strength 0.24
  12. Nirav C Thosani · 2 shared papers, 2022 · strength 0.24
  13. Dushyant V. Sahani · 2 shared papers, 2022 · strength 0.24
  14. Elena M. Stoffel · 2 shared papers, 2022 · strength 0.24
  15. Mandeep Sawhney · 2 shared papers, 2022 · strength 0.24
  16. Raffaella Casolino · 1 shared paper, 2023 · strength 0.20
  17. Michael J. Hall · 1 shared paper, 2023 · strength 0.20
  18. Pascal R. Hammel · 1 shared paper, 2023 · strength 0.20
  19. Andrew Victor Biankin · 1 shared paper, 2023 · strength 0.20
  20. Thomas P. Potjer · 1 shared paper, 2024 · strength 0.20
  21. Jason Scott Starr · 1 shared paper, 2024 · strength 0.20
  22. Yan Bi · 1 shared paper, 2024 · strength 0.20
  23. Aleksander M. Bogdanski · 1 shared paper, 2025 · strength 0.20
  24. Lydia G. van der Geest · 1 shared paper, 2025 · strength 0.20
  25. Bert A. Bonsing · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.